CareDx Receives CE Mark for AlloSeq HCT for Use in
CareDx Expands Transplant Portfolio in Europe...
Stay updated with breaking news from Caredx. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
CareDx Expands Transplant Portfolio in Europe...
24.05.2022 - Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased CareDx, Inc. (“CareDx” or the “Company”) (NASDAQ: CDNA) common stock between February 24, 2021 and May 5, 2022, inclusive (the ...
Donor-Derived Cell-Free DNA will be Used to Evaluate Treatment to Improve Lung Transplant Outcomes...
NEW YORK, May 16, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating...
Posters and Symposium Feature Latest Advances in AlloSeq Portfolio Including HLA Typing and Hematopoietic Stem Cell and Organ Transplant MonitoringSOUTH SAN FRANCISCO, Calif., May 11, 2022 (GLOBE NEWSWIRE)